Long-term pulmonary sequelae after treatment of childhood Hodgkin's disease

Annals of Oncology

Volumn 8, Issue SUPPL. 1, 1997, Pages

  Bossi, G ^a,b   Cerveri, I ^a   Volpini, E ^a   Corsico, A ^a   Baio, A ^a   Corbella, F ^a   Klersy, C ^a   Arico, M ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

childhood; Hodgkin's disease; late effects; lung function

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORMETHINE; DOXORUBICIN; IMIDAZOLECARBOXAMIDE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADOLESCENT; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; HODGKIN DISEASE; HUMAN; LUNG COMPLICATION; LUNG FUNCTION TEST; MALE; PRIORITY JOURNAL;

EID: 0031002373     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/8.suppl_1.S19     Document Type: Conference Paper

References (35)

1. Vecchi V, Pileri S, Burnelli R et al. Treatment of pediatric Hodgkin disease tailored to stage, mediastinal mass, and age. Cancer 1993; 72: 2049-57.
2. Hunger SP, Link MP, Donaldson SS. ABVD/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin's disease: The Stanford experience. J Clin Oncol 1994; 12: 2160-6.
3. Fryer CJ, Hutchinson RJ, Krailo M et al. Efficacy and toxicity of 12 courses of ABVD chemotherapy followed by low dose regional radiation in advanced Hodgkin's disease in children: A report from Children's Cancer Study Group. J Clin Oncol 1990; 8:1971-80.
4. Hudson MM, Greenwald C, Thompson E et al. Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with Hodgkin's disease. J Clin Oncol 1993; 11: 100-8.
5. Gehan EA, Sullivan MP, Fuller LM et al. The intergroup Hodgkin's disease in children: A study of stages I and II. Cancer 1990; 15:1429-37.
6. Valagussa P, Santoro A, Fossati-Bellani F et al. Second acute leukemia and other malignancies following treatment for Hodgkin's disease. J Clin Oncol 1986; 4: 830-7.
7. Kaldor JM, Day NE, Clarke A et al. Leukemia following Hodgkin's disease. N Engl J Med 1990; 322: 7-13.
8. Boivin JF, Hutchinson GB, Zauber AG et al. Incidence of second cancers in patients treated for Hodgkin's disease. J Natl Cancer Inst 1995; 87: 732-41.
9. Beaty O, Hudson MM, Greenwald C et al. Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease. J Clin Oncol 1995; 13: 603-9.
10. Doria R, Holford T, Farber LR et al. Second solid malignancies after combined modality therapy for Hodgkin's disease. J Clin Oncol 1995; 13: 2016-22.
11. Bhatia S, Robison LL, Oberlin O et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 1996; 334: 745-51.
12. Donaldson SS. Lesson from our children. Int J Radiat Oncol Biol Phys 1993; 26: 739-49.
13. Green DM, Gingell RL, Pearce J et al. The effect of mediastinal irradiation on cardiac function of patients treated during childhood and adolescence for Hodgkin's disease. J Clin Oncol 1987; 5: 239-45.
14. Kadota RP, Burgett O, Driscoll D. Cardiopulmonary function in long-term survivors of childhood Hodgkin's lymphoma. Mayo Clin Proc 1988; 63: 362-7.
15. Mefferd JM, Donaldson SS, Link MP. Pediatric Hodgkin's disease: Pulmonary, cardiac, and thyroid function following combined modality therapy. Int J Radiat Oncol Biol Phys 1989; 16: 679-85.
16. Hancock SL, Tucker MA, Hoper RT. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 1993; 270: 1949-55.
17. Morgan GW, Freeman AP, McLean RG et al. Late cardiac, thyroid, and pulmonary sequelae of mantle radiotherapy for Hodgkin's disease. Int J Radiat Oncol Biol Phys 1985; 11: 1925-31.
18. Cionini L, Pacini P, De Paola E et al. Respiratory function tests after mantle irradiation in patients with Hodgkin's disease. Acta Radiol 1984; 23: 401-9.
19. Smith LM, Mendenhall NP, Cicale MJ et al. Results of a prospective study evaluating the effects of mantle irradiation on pulmonary function. Int J Radiat Oncol Biol Phys 1988; 16: 79-84.
20. Tarbell NJ, Thompson L, Mauch P. Thoracic irradiation in Hodgkin's disease: Disease control and long-term complications. Int J Radiat Oncol Biol Phys 1990; 18: 275-81.
21. Ortin TT, Shostak CA, Donaldson SS. Gonadal status and reproductive function following treatment for Hodgkin's disease in childhood: The Stanford experience. Int J Radiat Oncol Biol Phys 1990; 19: 873-80.
22. Hancock SL, Cox RS, McDougall IR. Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 1991; 325: 599-605.
23. Bossi G, Larizza D, Sommaruga G et al. Reduced thyroid volume is frequently associated with thyroid dysfunction after treatment for childhood Hodgkin disease. Ann Oncol 1996; 7 (Suppl 3): 73 (Abstr 258).
24. Vecchi V, Bontempi N, Comelli A et al. Italian multicentric study AIEOP-MH'89 CNR for childhood Hodgkin's disease: Preliminary results and comparison with previous protocol AIEOP-MH'83 CNR. Med Pediatr Oncol 1993; 21: 576 (Abstr P88).
25. Report of the Working Party. Standardization of lung function tests. Eur Resp J 1993; 6: S16.
26. American Thoracic Society. Standardization of spirometry. Am J Resp Crit Care Med 1995; 152: 1107-36.
27. American Thoracic Society. Single-breath carbon monoxide diffuding capacity (transfer factor). Am J Resp Crit Care Med 1995; 152: 2185-98.
28. Rosenthal M, Bain SH, Cramer D et al. Lung function in white children aged 4 to 19 years. I. Spirometry. Thorax 1993; 48: 794-802.
29. Rosenthal M, Cramer D, Bain SH et al. Lung function in white children aged 4 to 19 years. II. Single breath analysis and plethysmography. Thorax 1993; 48: 803-8.
30. Tanner JM. Growth and Adolescence, 2nd ed. Oxford: Blackwell 1962.
31. ERS Consensus Statement. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Resp J 1995; 8:1398-420.
32. Nenadov Beck M, Meresse O, Hartmann O. Long-term pulmonary sequelae after autologous bone marrow transplantation in children without total body irradiation. Bone Marrow Transplant 1995; 16: 771-5.
33. Bauer KA, Skarin AT, Balikian JP et al. Pulmonary complications of chemotherapy regimens containing bleomycin. Am J Med 1983: 74: 557-63.
34. Dalgleish AG, Woods RL, Levi JA. Bleomycin pulmonary toxicity: Its relationship to renal dysfunction. Med Pediatr Oncol 1984; 12: 313-7.
35. Green DM. Effects of treatment for childhood cancer on vital organ systems. Cancer 1993; 71: 3299-305.